Featured News

Purdue pharmaceutical compound sounds the alarm on cancer cells and unleashes T cells

Andrew D. Mesecar named Distinguished Professor of Biochemistry

Purdue names new pediatric cancer research center for the late Tyler Trent

Boilermaker fans prepare to Hammer Down Cancer

Mesecar named director of the Purdue Institute for Cancer Research

First-in-class targeted microRNA therapy slows cancer tumor growth

Podcast Ep. 82: Purdue Institute for Cancer Research Raises $100,000 in Annual Challenge 5K

Thank you to everyone who participated in the 15th Annual Challenge 5K run/walk!

Take your next giant leap at the Purdue Institute for Cancer Research Challenge 5K run/walk on Saturday, April 15!

Purdue’s expansive cancer-fighting efforts reflected in new name

Imaging agent illuminates lung cancer tumors

Comparative oncology research center at Purdue to be named for Evan and Sue Ann Werling

Man’s best friend leads the way to early cancer detection

Affordable cervical cancer test holds life-preserving promise

Improving prostate cancer relapse forecast by 14 months

Your support matters!

Anvil used to train cancer researchers in big data analysis

Mesecar named interim director of Purdue Center for Cancer Research

New patent-pending method mass-produces antitumor cells to treat blood diseases and cancer

Surprise $8.5 million estate gift will fund more than 40 years of cancer research

Purdue University research instrumental in early development of FDA-approved advanced prostate cancer diagnostic and treatment

Scientists reverse pancreatic cancer progression in ‘time machine’ made of human cells

Tyler Trent endowment leads to breakthrough discoveries in cancer research

Treating cancers starts small: More than 100 Purdue scientists study cancer on the cellular level

Testing drugs within a tumor may combat pancreatic cancer drug resistance, ‘time machine’ suggests

Technology shines the light on ovarian cancer treatments

Walther Cancer Foundation $11 million investment to expand IU-Purdue bioinformatics collaboration

Novel testing platform designed for breast cancer cells

Purdue scientist identifies new target for wide array of cancers

New treatment approach uses killer cells to treat deadly brain tumors

Chemistry innovator widening, quickening uses of spectrometry

$2 million SBIR grant fast-tracks cancer drug platform technology, which aims to better treat relapse

Stretchable, wearable coils may make MRI, other medical tests easier on patients

Pancreatic cancer 'time machine’ exposes plot twist in cell growth and invasion

Study identifies interaction that promotes cancerous state in cells

Novel techniques for mining patented gene therapies offer promising treatment options for cancers, other diseases

Purdue-discovered ‘fluorescent markers’ to illuminate cancer, improve outcomes, receives FDA fast track as Phase 3 clinical trials begin

Dr. Andrew Mesecar, Deputy Director of the Purdue Center for Cancer Research, is Working with Global Scientists in the Race Against the Coronavirus

Pair of Purdue students continuing legacy of Tyler Trent in supporting cancer research, innovations

A technology devised to help reduce injection pain, swelling from some best-selling drugs

This ‘lemon’ could help machine learning create better drugs

Chemistry Professor Gaurav Chopra wins multiple ASPIRE Awards

An engineering approach to reduce the pain of chemotherapy

Could Anthrax Help Fight Bladder Cancer?

Getting cancer drugs to the brain is difficult – but a new ‘road map’ might make it easier

Purdue University Chemistry Professor Creates Device to Combat Cancer Drug Cost

Cancer Bioinformatics Q&A - Purdue and IU Partners in Cutting Edge Cancer Technology

Can herbicides cause breast cancer? Purdue and INSERM scientists discover a piece to the puzzle.

A case for personalized medicine in the search for answers about cancer

Epigenetics offers puzzling twists and turns, but also possible cancer treatments

Big Data Approach to Cancer Focus of New Purdue Partnership

Big data approach to cancer is focus of new Purdue partnership

Structural Biology Used to Gain Insight into the Mechanism of Action of Covalent Inhibitors of the Deubiquitinase UCHL1

‘A first for cancer research’: New approach to study tumors

New anticancer agents have potential to better control tumor growth in nearly every cancer type

Purdue ranks 12th among worldwide universities granted U.S. utility patents for 2018

Tyler Trent’s donated cells to help trio of new research projects

Legislation to support cancer research passes Senate